277 related articles for article (PubMed ID: 19121188)
1. Delayed intravascular haemolysis following multiple asymptomatic ABO-incompatible red blood cell transfusions in a patient with hepatic failure.
Tormey CA; Stack G
Vox Sang; 2008 Oct; 95(3):232-5. PubMed ID: 19121188
[TBL] [Abstract][Full Text] [Related]
2. [Advancement in the preparation of red cell concentrates and platelet concentrates].
Inaba S
Masui; 2011 Jan; 60(1):23-30. PubMed ID: 21348247
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
4. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.
Sadani DT; Urbaniak SJ; Bruce M; Tighe JE
Transfus Med; 2006 Oct; 16(5):375-9. PubMed ID: 16999762
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of ABO-incompatible RBC transfusions.
Janatpour KA; Kalmin ND; Jensen HM; Holland PV
Am J Clin Pathol; 2008 Feb; 129(2):276-81. PubMed ID: 18208808
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic transfusion reaction due to anti-IH.
Irani MS; Richards C
Transfusion; 2011 Dec; 51(12):2676-8. PubMed ID: 21658050
[TBL] [Abstract][Full Text] [Related]
7. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
9. Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review.
McCullagh J; Cardigan R; Brunskill SJ; Bullock T; Doree C; Estcourt L; Huish S; Sandercock J; Green L
Blood Rev; 2022 Nov; 56():100989. PubMed ID: 35871104
[TBL] [Abstract][Full Text] [Related]
10. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
11. [A patient rescued from unexpected intraoperative massive hemorrhage with ABO incompatible blood transfusion].
Ohira N; Hoshi T; Yoneda T; Kono K; Asada A
Masui; 2009 Apr; 58(4):477-9. PubMed ID: 19364015
[TBL] [Abstract][Full Text] [Related]
12. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
13. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
14. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Iseki T; Yamaguchi T; Tojo A; Asano S
Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845
[TBL] [Abstract][Full Text] [Related]
15. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
[TBL] [Abstract][Full Text] [Related]
16. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
[TBL] [Abstract][Full Text] [Related]
17. Failure of bedside ABO testing is still the most common cause of incorrect blood transfusion in the Barcode era.
Ahrens N; Pruss A; Kiesewetter H; Salama A
Transfus Apher Sci; 2005 Aug; 33(1):25-9. PubMed ID: 15964241
[TBL] [Abstract][Full Text] [Related]
18. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
Yazer MH; Triulzi DJ
Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
[TBL] [Abstract][Full Text] [Related]
19. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
